Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Research Article

Anti-anxiety and Hypnotic Effects of Lawsonia inermis Hydroalcoholic Extract

Author(s): Ali Mohammad Pourbagher-Shahri, Hassan Rakhshandeh, Keyvan Sabahi, Mahmoud Hosseini and Fatemeh Forouzanfar*

Volume 21, Issue 4, 2024

Published on: 02 February, 2023

Page: [718 - 723] Pages: 6

DOI: 10.2174/1570180820666230119162349

Price: $65

Abstract

Background: Sleep is a vital biological feature, and insomnia causes maladaptive physical and psychological functions. The main flaws of current insomnia medications are significant side effects. A suitable substitute can be herbal products. We aimed to evaluate the anti-anxiety, sleep-inducing, and - prolonging effects of Lawsonia inermis extract and fractions in mice.

Methods: Male albino mice were pretreated intraperitoneally (i.p.) with either three doses (40, 80, and 160 mg/kg) of L. inermis extract or n-butanol fraction (NBF), ethyl acetate fraction (EAF), and water fraction (WF), 30 minutes before i.p. injection of 30 mg/kg pentobarbital. Sleep latency and duration of sleep were recorded. For anxiolytic activity, elevated plus-maze (EPM) tests were used. Moreover, the toxicity of the extract was determined in both in vivo and in vitro experiments.

Results: L. inermis extract (160 mg/kg) significantly reduced sleep latency and increased sleep duration. EAF at 160 mg/kg decreased sleep latency and increased sleep duration. Flumazenil reversed the hypnotic effect of L. inermis extract (160 mg/kg). L. inermis extract (80, 160 mg/kg) increased the time spent and the number of entries in the open arms of EPM. The tested extracts and fractions administration found no adverse effects on PC12 cell viability. The LD50 was 2.4 g/kg.

Conclusion: L. inermis extracts exhibit anxiolytic and hypnotic effects, probably modulating the GABAergic system.

Graphical Abstract

[1]
Riemann, D.; Krone, L.B.; Wulff, K.; Nissen, C. Sleep, insomnia, and depression. Neuropsychopharmacology, 2020, 45(1), 74-89.
[http://dx.doi.org/10.1038/s41386-019-0411-y] [PMID: 31071719]
[2]
Siegel, J.M. Sleep viewed as a state of adaptive inactivity. Nat. Rev. Neurosci., 2009, 10(10), 747-753.
[http://dx.doi.org/10.1038/nrn2697] [PMID: 19654581]
[3]
Tononi, G.; Cirelli, C. Sleep function and synaptic homeostasis. Sleep Med. Rev., 2006, 10(1), 49-62.
[http://dx.doi.org/10.1016/j.smrv.2005.05.002] [PMID: 16376591]
[4]
Diekelmann, S.; Born, J. The memory function of sleep. Nat. Rev. Neurosci., 2010, 11(2), 114-126.
[http://dx.doi.org/10.1038/nrn2762] [PMID: 20046194]
[5]
Maquet, P. The role of sleep in learning and memory. Science, 2001, 294(5544), 1048-1052.
[http://dx.doi.org/10.1126/science.1062856] [PMID: 11691982]
[6]
Neubauer, D.N.; Pandi-Perumal, S.R.; Spence, D.W.; Buttoo, K.; Monti, J.M. Pharmacotherapy of Insomnia. J. Cent. Nerv. Syst. Dis., 2018, 10, 1179573518770672.
[http://dx.doi.org/10.1177/1179573518770672] [PMID: 29881321]
[7]
Shi, Y.; Dong, J.W.; Zhao, J.H.; Tang, L.N.; Zhang, J.J. Herbal insomnia medications that target gabaergic systems: A review of the psychopharmacological evidence. Curr. Neuropharmacol., 2014, 12(3), 289-302.
[http://dx.doi.org/10.2174/1570159X11666131227001243] [PMID: 24851093]
[8]
Rakhshandeh, H.; Heidari, A.; Pourbagher-Shahri, A.M.; Rashidi, R.; Forouzanfar, F. Hypnotic effect of a. absinthium hydroalcoholic extract in pentobarbital-treated mice. Neurol. Res. Int., 2021, 2021, 5521019.
[http://dx.doi.org/10.1155/2021/5521019] [PMID: 33968448]
[9]
Rakhshandeh, H.; Rashidi, R.; Vahedi, M.M.; Khorrami, M.B.; Abbassian, H.; Forouzanfar, F. Hypnotic activity of Capparis spinosa hydro-alcoholic extract in mice. Recent Pat. Food Nutr. Agric., 2021, 12(1), 58-62.
[http://dx.doi.org/10.2174/2212798411666200727151142] [PMID: 32718304]
[10]
Ishola, I.O.; Katola, F.O.; Adeyemi, O.O. Involvement of GABAergic and nitrergic systems in the anxiolytic and hypnotic effects of Curcuma longa: its interaction with anxiolytic-hypnotics. Drug Metab. Pers. Ther., 2020, 36(2), 135-143.
[PMID: 33780193]
[11]
Hamedi, S.; Forouzanfar, F.; Rakhshandeh, H.; Arian, A. Hypnotic effect of Portulaca oleracea on pentobarbital-induced sleep in mice. Curr. Drug Discov. Technol., 2019, 16(2), 198-203.
[http://dx.doi.org/10.2174/1570163815666180308142543] [PMID: 29521239]
[12]
Semwal, R.B.; Semwal, D.K.; Combrinck, S.; Cartwright-Jones, C. Lawsonia inermis L. (henna): Ethnobotanical, phytochemical and pharmacological aspects. 2014, 155(1), 80-103.
[13]
Ali, B.H.; Bashir, A.K.; Tanira, M.O.M. Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis L. (henna) in rats. Pharmacology, 1995, 51(6), 356-363.
[http://dx.doi.org/10.1159/000139347] [PMID: 8966192]
[14]
Hadisi, Z.; Nourmohammadi, J.; Nassiri, S.M. The antibacterial and anti-inflammatory investigation of Lawsonia inermis-gelatin-starch nano-fibrous dressing in burn wound. Int. J. Biol. Macromol., 2018, 107(Pt B), 2008-2019.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.10.061] [PMID: 29037870]
[15]
Babu, P.D.; Subhasree, R. Antimicrobial activities of Lawsonia inermis-a review. Acad J Plant Sci., 2009, 2(4), 231-232.
[16]
Mikhaeil, B.R.; Badria, F.A.; Maatooq, G.T.; Amer, M.M.A. Antioxidant and immunomodulatory constituents of henna leaves. Z. Naturforsch. C J. Biosci., 2004, 59(7-8), 468-476.
[http://dx.doi.org/10.1515/znc-2004-7-803] [PMID: 15813363]
[17]
Rakhshandeh, H.; Ghorbanzadeh, A.; Negah, S.S.; Akaberi, M.; Rashidi, R.; Forouzanfar, F. Pain-relieving effects of Lawsonia inermis on neuropathic pain induced by chronic constriction injury. Metab. Brain Dis., 2021, 36(7), 1709-1716.
[http://dx.doi.org/10.1007/s11011-021-00773-w] [PMID: 34169409]
[18]
Salmani, H.; Hosseini, M.; Baghcheghi, Y.; Moradi-Marjaneh, R.; Mokhtari-Zaer, A. Losartan modulates brain inflammation and improves mood disorders and memory impairment induced by innate immune activation: The role of PPAR-γ activation. Cytokine, 2020, 125, 154860.
[http://dx.doi.org/10.1016/j.cyto.2019.154860] [PMID: 31574424]
[19]
Abrams, R.M. Sleep deprivation. Obstet. Gynecol. Clin. North Am., 2015, 42(3), 493-506.
[http://dx.doi.org/10.1016/j.ogc.2015.05.013] [PMID: 26333639]
[20]
Sleep disorders and sleep deprivation: An unmet public health problem. Colten, H.R.; Altevogt, B.M., Eds.;Institute of Medicine Committee on Sleep Medicine, Research; National Academies Press (US): Washington (DC), 2006.
[http://dx.doi.org/10.17226/11617] [PMID: 20669438]
[21]
Borrás, S.; Martínez-Solís, I.; Ríos, J.L. Medicinal plants for insomnia related to anxiety: An updated review. Planta Med., 2021, 87(10-11), 738-753.
[http://dx.doi.org/10.1055/a-1510-9826] [PMID: 34116572]
[22]
Wan, X.; Mathers, D.A.; Puil, E. Pentobarbital modulates intrinsic and GABA-receptor conductances in thalamocortical inhibition. Neuroscience, 2003, 121(4), 947-958.
[http://dx.doi.org/10.1016/j.neuroscience.2003.07.002] [PMID: 14580945]
[23]
Forouzanfar, F.; Ghorbani, A.; Hosseini, M.; Rakhshandeh, H. Hydroalcoholic extract of needles of Pinus eldarica enhances pentobarbital-induced sleep: possible involvement of GABAergic system. Avicenna J. Phytomed., 2016, 6(4), 449-457.
[PMID: 27516986]
[24]
Nesa, L.; Munira, S.; Mollika, S.; Islam, M.; Choin, H.; Chouduri, A.U.; Naher, N. Evaluation of analgesic, anti-inflammatory and CNS depressant activities of methanolic extract of Lawsonia inermis barks in mice. Avicenna J. Phytomed., 2014, 4(4), 287-296.
[PMID: 25068143]
[25]
Bhattacharya, S.K.; Satyan, K.S. Experimental methods for evaluation of psychotropic agents in rodents: I-Anti-anxiety agents. Indian J. Exp. Biol., 1997, 35(6), 565-575.
[PMID: 9357158]
[26]
Gottesmann, C. GABA mechanisms and sleep. Neuroscience, 2002, 111(2), 231-239.
[http://dx.doi.org/10.1016/S0306-4522(02)00034-9] [PMID: 11983310]
[27]
Alnamer, R.; Alaoui, K.; Bouidida, H.; Benjouad, A.; Cherrah, Y. Sedative and hypnotic activities of the methanolic and aqueous extracts of Lavandula officinalis from Morocco. Adv. Pharmacol. Sci., 2012, 2012, 270824.
[http://dx.doi.org/10.1155/2012/270824] [PMID: 22162677]
[28]
Dubovsky, S.L.; Marshall, D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother. Psychosom., 2022, 91(5), 307-334.
[http://dx.doi.org/10.1159/000524400] [PMID: 35504267]
[29]
Ghit, A.; Assal, D.; Al-Shami, A.S.; Hussein, D.E.E. GABAA receptors: Structure, function, pharmacology, and related disorders. J. Genet. Eng. Biotechnol., 2021, 19(1), 123.
[PMID: 34417930]
[30]
Gallo, A.T.; Hulse, G. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data. J. Psychopharmacol., 2021, 35(3), 211-220.
[http://dx.doi.org/10.1177/0269881120981390] [PMID: 33426982]
[31]
Walf, A.A.; Frye, C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc., 2007, 2(2), 322-328.
[http://dx.doi.org/10.1038/nprot.2007.44] [PMID: 17406592]

© 2024 Bentham Science Publishers | Privacy Policy